By Dawn Fukuda, Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair (Incoming)
Dawn Fukuda, Director, Office of HIV/AIDS, Massachusetts Department of Public Health and NASTAD Chair
For perhaps the first time in history, the end of HIV/AIDS and hepatitis is within our reach. Recent notable achievements provide promise for success, among them the release of the National HIV/AIDS Strategy (NHAS) and the Viral Hepatitis Action Plan (VHAP) and the passage of the Affordable Care Act (ACA). Collectively, these achievements have catalyzed the beginning of a radical transformation in our healthcare systems for communities impacted by HIV and hepatitis. In particular, the ACA represents an opportunity for the country to expand access to HIV/AIDS and hepatitis prevention, medical care, and health promotion services in profound and impactful ways. The systems-level changes advanced in the legislation also require state health departments to reassess their role in the context of an evolving health care system and the other sources of financing that may become available to support what have historically been public health functions—this is particularly the case for HIV/AIDS and viral hepatitis prevention and care services. Continue reading
By Liisa M. Randall, Consultant and Amy Killelea, Senior Manager, Health Care Access, NASTAD
With federal and state funding for HIV/AIDS and viral hepatitis services increasingly constrained, it is essential that health departments explore alternative sources of support to ensure the sustainability of vital services. Full implementation of the Affordable Care Act (ACA) provides new opportunities for health departments and implementing partners to leverage resources made available through third-party reimbursement. Please visit NASTAD’s health reform website for resources on what the ACA means for HIV/AIDS and viral hepatitis programs and services, and how health departments are preparing for reform. Continue reading
By Amy Killelea, Senior Manager, Health Care Access, NASTAD
On April 9th, the Centers for Medicare and Medicaid Services (CMS) released a funding opportunity announcement (FOA) for eligible entities to serve as Patient Navigators in federally facilitated and partnership exchanges/marketplaces (state-run exchanges/marketplaces will be administering their own Patient Navigator programs). To access the funding opportunity announcement, visit: http://www.grants.gov, and search for CFDA #93.750. See the Kaiser Family Foundation map to the right to see which type of exchange/marketplace your state will have.
FOR IMMEDIATE RELEASE: April 2, 2013
Contact: Meico Whitlock, 202-434-8094, www.NASTAD.org
ADAP Enrolling and Serving More Clients than Ever Before; Future Funding Uncertain
Washington, DC – Today, the National Alliance of State and Territorial AIDS Directors (NASTAD) released the second and final module of its 2013 National ADAP Monitoring Project Annual Report. The National ADAP Monitoring Project is NASTAD’s long-standing effort to document new developments and challenges facing AIDS Drug Assistance Programs (ADAPs), assessing key trends over time and providing the latest available data on the status of ADAPs. For the last 18 years, NASTAD has provided comprehensive analysis about ADAPs through The Report.
By Oscar Mairena, Manager of Viral Hepatitis and Policy and Legislative Affairs, NASTAD
Oscar Mairena, Manager, Viral Hepatitis/Policy and Legislative Affairs, NASTAD
This weekend marks the third anniversary of the passage of the Patient Protection and Affordable Care Act (ACA). The ACA improves access to care and preventive services through expansion of public and private insurance, reforms that eliminate discriminatory insurance practices and make insurance coverage more affordable, and significant investments in prevention, care coordination, and health workforce and infrastructure. In the case of viral hepatitis, the ACA provides an opportunity to not only improve access to essential care and treatment for people living with viral hepatitis, but to diagnose viral hepatitis earlier and prevent new infections. In light of the ACA’s anniversary, NASTAD released a primer today on viral hepatitis and the ACA, The Affordable Care Act and the Silent Epidemic: Increasing the Viral Hepatitis Response through Health Reform. The primer provides an overview of how health reform impacts viral hepatitis prevention, screening, linkage and retention to care, and treatment.